Impact Factor: 4.75
News & Views Virtual Issue
Quick Links: 2011 / 2010 / 2009 / 2008
2011
β-catenin in metastatic melanoma - The smoking gun reloaded
Terry Van Dyke and Glenn Merlino
Coding genes join the non-coding world
Sergei A. Manakov and Jing Crystal Zhao
Can having fun protect you from obesity and its cancer risk?
Sheila Collins
The gluttonous side of malignant melanoma: Basic and clinical implications of macroautophagy
Agnieszka Checinska and María S. Soengas
A new mutation with STAGgering effects
J. William Harbour
The Three M’s: Melanoma, MITF and MicroRNA
Rachel E. Bell and Carmit Levy
Glutamate Receptors: Emerging Players in Melanomagenesis
Janet Wangari-Talbot and Suzie Chen
Induction of senescence in melanoma: thinking outside the cell
Narendra Wajapeyee and Michael R. Green
Serine biosynthesis: fuel for the melanoma cell growth engine
Stephen G. Dann and Robert T. Abraham
DUB for MITF: no myth, some dubiety
Serge Y. Fuchs
Melanoma researchers have a reason to GRIN: melanoma yields more of its secrets to exome sequencing
Paul Meltzer
If you can't beat me, join me: collaborating oncogenes circumventing senescence and causing cancer
Patrick A Possik and Daniel S Peeper
Targeting Leucine addiction and autophagy in melanoma
Maria T. Diaz-Meco
Niche work when you can get it: Collagen XVII and the melanocyte stem cell
Rasmus Freter
Separating melanins into their primary colors: quantifying contributions from eumelanin and pheomelanin
John D. Simon
Melanocytes and melanoma: hooked on elongation
James A. Lister
Evolution in Action: Highlighting a Role for the Agouti Gene in Development?
Ian Jackson
A fitness model for melanoma-initiating cells
Bradley J. Kubick and Dennis R. Roop
Illuminating progression: tracking melanoma metastasis in a gene therapy setting
Chi-Ping Day and Glenn Merlino
MITF: the power and the glory (pages 262–263)
Keith S. Hoek
(Mela)statin’ the not so obvious: tumor suppressor hidden in intron
Ashley M. Poenitzsch, Vijayasaradhi Setaluri and Vladimir S. Spiegelman
Unwelcome guests: macrophages promote UV-induced melanoma
William E. Damsky and Marcus Bosenberg
Uveal Melanoma and GNA11 Mutations: a new piece added to the puzzle
Ahmad Besaratinia, Gerd P. Pfeifer
Melanoma and DNA damage from a distance (farstander effect)
Shobhan Gaddameedhi and Aziz Sancar
Fitting MITF regulation of PDE4D3 into the skin pigmentation puzzle
Mickael Ohanna, Corine Bertolotto and Robert Ballotti
Mind the BAP
Andrew E. Aplin and Takami Sato
Stress-sensing toll-like receptor as a driver of angiogenesis
Xiang-Yang Wang, Devanand Sarkar and Paul B. Fisher
Red hair or not – reassessment of melanoma risk among CDKN2A carriers
Marianne Berwick
Is UV-induced mutation formation in melanocytes different from other skin cells?
Thomas M. Rünger
Turing patterns: how the fish got its spots
Hillery C. Metz, Marie Manceau and Hopi E. Hoekstra
A new delta-COP on the block – linking pigmentation defects with neurodegeneration
Wolfgang Wagner and John A. Hammer III
Melanoma and viagra: an unexpected connection
Devarati Mitra, Kathleen C. Robinson and David E. Fisher
2010
‘Going green’ against skin cancer
Mariam Malik and Stuart Yuspa
Of swords and ploughshares: Immunosurveillance and inflammation in melanoma
Thomas Tüting
4E-BPs at the crossroads of oncogenic MAPK and AKT signaling
Ivan Topisirovic and Nahum Sonenberg
Smoke and miRrors: pseudogenes tricking miRNAs
Meifan Chen
TRP-ing off the p53 apoptotic switch
Afshan Ahmed and Margaret Ashcroft
Improved melanoma survival at last! Ipilimumab and a paradigm shift for immunotherapy
Thomas F. Gajewski
Not quite as old as the sun
Estela E. Medrano
Ipilimumab for metastatic melanoma: A paradigm shift in cancer immunotherapy
Thomas F. Gajewski
Dicing with death: Mitf regulates DICER
Colin R. Goding
Sex-specific coloration for display and camouflage
Heinz Arnheiter
What tumor vessels can tell us
Sunyoung Lee
Exploring melanoma's massively parallel universe
Keith S. Hoek
The quest for the melanoma stem cell: Still more questions than answers
Florian Rambow, Lionel Larue
Chemokines in tumor microenvironment revealed
Ann Richmond
Mutation spectrum of the first melanoma genome points finger firmly at ultraviolet light as the primary carcinogen
Nicholas K. Hayward
Programming T cells for adoptive T cell transfer therapy
Paul Chapman
C-end your drugs using peptide tags
Dan Niculescu-Duvaz, Caroline Springer, Richard Marais
Regulation of Raf activity by dimerization
Hua Wei, Ming-Ming Zhou
Anticipating drug resistance in the MAP kinase pathway
Ronen Marmorstein
Melanocytes don't always take the high road
Hun-Way Hwang, William J. Pavan
A colorful explanation for atrial arrhythmias
Benjamin F. Remo, Glenn I. Fishman
Anticipating drug resistance in the MAP kinase pathway
Ronen Marmorstein
Melanocytes don't always take the high road
Hun-Way Hwang, William J. Pavan
Piecing together the pigment-type switching puzzle
Will P. Walker, Teresa M. Gunn
Moesin/ezrin: a specific role in cell metastasis?
Dominique Lallemand, Monique Arpin
TYRO3-mediated regulation of MITF: a novel target in melanoma?
Udo Rudloff, Yardena Samuels
2009
Unique transforming properties of Notch1 in human melanocytes
Barbara Bedogni, Marianne Broome Powell
Functional role of MITF phosphorylation. In vivo veritas?
Corine Bertolotto, Robert Ballotti
Double stranded RNA tricks melanoma cells into committing suicide
Romina S. Goldszmid, Uzma A. Hasan, Giorgio Trinchieri
Classic versus non-classic: A survival Kit for life in the skin
Shigeyuki Uehara, Akiha Kawasaki, Hiroaki Yamamoto
Mutated ERBB4: a novel drug target in metastatic melanoma?
Kari Kurppa, Klaus Elenius
Gray zone prompting new imagination
Shinichi Nishikawa
Secrets to developing Wnt-age melanoma revealed
Lionel Larue, Véronique Delmas
F-box proteins FBXO31 and FBX4 in regulation of cyclin D1 degradation upon DNA damage
Lijun Jia, Yi Sun
Complexities of cuticular pigmentation in insects
Manickam Sugumaran
MITF pathway mutations in melanoma
Satoru Yokoyama, Nunciada Salma, David E. Fisher
GOLPH3 links the Golgi network to mTOR signaling and human cancer
Robert T. Abraham
Mysteries of salt and pepper
Bhushan Sarode, Friedrich Beermann
Seeing red: pheomelanin synthesis uncovered
John D. Simon
Melanocytes out-foxed
James A. Lister
The long arm of BRAFV600E gets to mTORC1
Pablo Lopez-Bergami
June 2009
Building the perfect beast: complex mouse models teach surprisingly simple melanoma lessons
Glenn Merlino
June 2009
Wild-type versus mutant MMP-8 in melanoma: 'When you come to a fork in the road, take it'*
Jessica S. Blackburn, Constance E. Brinckerhoff
June 2009
Eating thyself toward the dark side?
Michael S. Marks
June 2009
Agouti signal protein: crossing the 'yellow' signal and arriving to pathways that affect tumorgenesis
Zalfa A. Abdel-Malek
June 2009
Canine coloration: dark domesticated dogs and the bright side for wild wolves
Kevin J. McGraw
June 2009
How TGF-ß and PAX3 regulate suntanning
Mary R. Loeken
April 2009
Maximizing tumor cell invasion
Pat P. Ongusaha, Sam W. Lee
April 2009
Snail puts melanoma on the fast track
Thomas Herzinger, Dieter A. Wolf
April 2009
Lipid-mediated signalling and melanocyte function
Mauro Picardo
April 2009
Are suberythemal doses of ultraviolet B good for your skin?
Andrzej Slominski
April 2009
Mouse pigmentation mutants help identify a uveal melanoma oncogene
Nicholas K. Hayward
February 2009
Cracking the system: melanoma complexity demands new therapeutic approaches
Adina Vultur, Meenhard Herlyn
February 2009
Stemming the flood
Keith S. Hoek, Ossia M. Eichhoff, Daniel Widmer, Reinhard Dummer
February 2009
Stepping on the GAS: a brake pedal for melanoma metastasis?
Marika Linja, Levi A. Garraway
February 2009
The expanding role and presence of neuromelanins in the human brain – why gray matter is gray
Vincent J. Hearing
February 2009
Melanins seem to be everywhere in the body, but for what?
Shosuke Ito
February 2009
2008
Looping tumor suppression
Maria S. Soengas
December 2008
'How tyrosinase got its copper'– not a Just So Story!
Vijayasaradhi Setaluri
December 2008
Riding 'white' horses reveals new insights into pigmentation and melanoma
Belinda J. Norris
December 2008
Ribosomes and p53 – a new KIT for skin darkening
Heinz Arnheiter, Kapil Bharti
October 2008
The ARFul truth about melanoma susceptibility genes
Glenn Merlino
October 2008
Searching for the Achilles' heel of melanoma cells: new treatment modalities
Vladislava O. Melnikova, Menashe Bar-Eli
October 2008
Expanding the genetic spectrum of pigmentation
Boris C. Bastian, Daniel Pinkel
October 2008
Effectively targeting BRAF in melanoma: a formidable challenge
Leslie A Fecher, Ravi Amaravadi, Lynn M. Schuchter
August 2008
All for one, one for all: alternative promoters and Mitf
Eiríkur Steingrímsson
August 2008
Colourless side of the nude mutation: Foxn1 and hair pigmentation
Hitomi Aoki, Takahiro Kunisada
June 2008
Neanderthal man's MC1R plays fair
Eugene Healy
June 2008
A shining future for NR4A nuclear receptors in DNA repair
Thijs W.H. Pols, Carlie J.M. de Vries
June 2008
SLC24A5: exchanging genetic and biochemical knowledge
Ellen E. Quillen, Mark D. Shriver
June 2008
Perspectives on the structure and function of melanin
John D. Simon, Małgorzata Różanowska
June 2008
Melanoma initiating cells – easy as ABC?
Anindita Bhoumik, Ze'ev Ronai
April 2008
A pigment evolution Kitlg
Emma R. Greenhill, Robert N. Kelsh
April 2008
Human 'coat colour' genetics
Richard A. Sturm
April 2008
SOX9 and the tanning response: something new under the sun
Jose Carlos Garcia-Borron
February 2008
A new mechanism of release from senescence: suppression of p16INK4a by beta-catenin
David P. Curley, Marcus W. Bosenberg
February 2008
ß-Defensin 3: a novel and unexpected key that unlocks the melanocortin 1 receptor
Zalfa A. Abdel-Malek, Dorothy Supp
February 2008
MYC-induced sensitivity of human malignant melanoma to proteasome inhibitors – a KaMYCaze effect
Serge Y. Fuchs
February 2008
